POLE and ovarian cancer: Five female POLE ED variant heterozygotes developed ovarian cancer (OC) between the ages of 33 and 45, including one with bilateral disease age 40 years, but no OCs were found in POLD1 ED variant heterozygotes (Fisher’s exact test, p = 0.31)).